Skip to main content
OpenTrials
Completed

NCT Number: NCT00765934

Influence of Rapydan on Clinical Chemistry and Hematology Measurements

There is an increasing awareness of the importance of treating procedure-related pain. Patients undergoing vascular access procedures are often afraid of needles and the discomfort associated with injections. This type of pain and/or fear can be stressful to patients. [1] For prevention of the pain associated with these procedures, the hospital is using Rapydan plasters. Rapydan consists out of two local anesthetics: lidocaine and tetracaïne. Rapydan produces topical anesthesia after an application time of 30 minutes and is used in the Martini Hospital for pain relieve by venipuncture and IV cannulation. The venous blood draining the anaesthetized skin contains a higher blood concentration of the local anesthetics than does venous blood in other parts of the body [2] Although the concentrations of the local anesthetics are low in patients with normal skin, the question is whether the presence of the local anesthetics which Rapydan contains might influence routine measurements in clinical chemistry and hematology.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

20 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

LabNoord

Groningen, Provincie Groningen, Netherlands

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Volunteers 20-60 years who are decision making competent

Exclusion criteria

Patients with local anesthetic allergy Patients using antiarrhythmic drugs Patients using other local anesthetics

Treatment and study plan

Rapydan

Drug

lidocaine / tetracaine 70/70 mg patch

Other names: Lidocaine Tetracaine Patch

Primary outcomes

  1. Routine Clinical Chemistry measurements differences

    Time frame: 1

Sponsors and collaborators

Lead sponsor

LabNoord

Other

Registry information

Official study title

Does Rapydan Influence Routine Clinical Chemistry and Hematology Measurements?

Important dates

Study start
2009
Primary completion
2010
Study completion
2010
First posted
Oct 3, 2008
Registry last updated
May 18, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.